ALPHAMAB-B (09966) announced on October 24, 2025, that the company has resolved under its restricted share reward plan to grant a total of 1.9902 million reward shares to three eligible participants, including Dr. Xu Ting (Chairman and Executive Director), Ms. Liu Yang (Executive Director), and one employee of the group. The shares are to be issued for the subscription of up to a total of 1.9902 million common shares with a par value of $0.000002 each, subject to acceptance by the rewarded directors and employees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.